Ryan Sun
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 33
- CAR-T cell therapy research 13
- Cancer Immunotherapy and Biomarkers 6
- Colorectal Cancer Treatments and Studies 5
-
- Cancer Genomics and Diagnostics 9
- Co-authors
- Xihong Lin (9 shared papers)Kanwal P. S. Raghav (6 shared papers)Lili Wu (1 shared paper)Lu Yang (2 shared papers)Ping Yin (1 shared paper)Steven Zimmerly (1 shared paper)Hongfei Zhou (1 shared paper)Shirley Hui (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)JAMA Oncology (5 papers)JCO Precision Oncology (3 papers)Nature Communications (3 papers)Biometrics (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Ryan Sun
97 papers receiving 2.6k citations
Ryan Sun's Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 1.1k
- Hepatology 201
- Cancer Research 274
- Genetics 501
- Immunology 303
Countries citing papers authored by Ryan Sun
This map shows the geographic impact of Ryan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Sun more than expected).
Fields of papers citing papers by Ryan Sun
This network shows the impact of papers produced by Ryan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Sun. The network helps show where Ryan Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas Hit paper breakdown → | 2020 | 480 |
| 2 | Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial Hit paper breakdown → | 2022 | 221 |
| 3 | 2021 | 168 | |
| 4 | 2021 | 162 | |
| 5 | 2020 | 161 | |
| 6 | Survival improvement for patients with metastatic colorectal cancer over twenty years Hit paper breakdown → | 2023 | 121 |
| 7 | 2011 | 96 | |
| 8 | 2020 | 70 | |
| 9 | 2022 | 67 | |
| 10 | 2022 | 65 | |
| 11 | 2021 | 58 | |
| 12 | 2022 | 55 | |
| 13 | 2022 | 45 | |
| 14 | SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Hit paper breakdown → | 2025 | 45 |
| 15 | 2019 | 44 | |
| 16 | 2022 | 40 | |
| 17 | 2023 | 39 | |
| 18 | 2010 | 38 | |
| 19 | 2019 | 36 | |
| 20 | 2022 | 32 |
About Ryan Sun
Ryan Sun is a scholar working on Oncology, Cancer Research, Genetics, Statistics and Probability and Pathology and Forensic Medicine, having authored 105 papers that have together received 2.7k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (15 papers), CAR-T cell therapy research (13 papers), Cancer Genomics and Diagnostics (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Colorectal Cancer Treatments and Studies (5 papers), RNA modifications and cancer (5 papers) and Statistical Methods in Clinical Trials (5 papers). The work is most often cited by research in Oncology (1.1k citations), Hepatology (201 citations), Cancer Research (274 citations), Genetics (501 citations) and Immunology (303 citations). Ryan Sun has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Xihong Lin, Kanwal P. S. Raghav, Lili Wu, Lu Yang, Ping Yin, Steven Zimmerly, Hongfei Zhou, Shirley Hui, Scott Kopetz and David Christiani. Their work appears in journals such as Journal of Clinical Oncology, JAMA Oncology, JCO Precision Oncology, Nature Communications and Biometrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.